[go: up one dir, main page]

WO2008006969A3 - Nouveaux derives tetracycuques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux derives tetracycuques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Download PDF

Info

Publication number
WO2008006969A3
WO2008006969A3 PCT/FR2007/001174 FR2007001174W WO2008006969A3 WO 2008006969 A3 WO2008006969 A3 WO 2008006969A3 FR 2007001174 W FR2007001174 W FR 2007001174W WO 2008006969 A3 WO2008006969 A3 WO 2008006969A3
Authority
WO
WIPO (PCT)
Prior art keywords
contain
preparation
pharmaceutical compositions
novel tetracyclic
tetracyclic derivatives
Prior art date
Application number
PCT/FR2007/001174
Other languages
English (en)
Other versions
WO2008006969A2 (fr
Inventor
Helgoual Ch Jean-Martial L
Naour Morgan Le
Pascal Berthelot
Nicolas Lebegue
Veronique Leclerc
Pascal Carato
Catherine Dacquet
Alain Ktorza
Daniel-Henri Caignard
Original Assignee
Servier Lab
Helgoual Ch Jean-Martial L
Naour Morgan Le
Pascal Berthelot
Nicolas Lebegue
Veronique Leclerc
Pascal Carato
Catherine Dacquet
Alain Ktorza
Daniel-Henri Caignard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Helgoual Ch Jean-Martial L, Naour Morgan Le, Pascal Berthelot, Nicolas Lebegue, Veronique Leclerc, Pascal Carato, Catherine Dacquet, Alain Ktorza, Daniel-Henri Caignard filed Critical Servier Lab
Publication of WO2008006969A2 publication Critical patent/WO2008006969A2/fr
Publication of WO2008006969A3 publication Critical patent/WO2008006969A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Composés de fomαule (I) : dans laquelle : > R1, R2 et R3, tels que décrits dans la description forment un cycle de formule (II) où R6 représente un atome d'hydrogène ou d'halogène, ou un groupement alkyle, alkoxy, amino, alkylamino, ou dialkylamino, et X représente un atome d'hydrogène ou un groupement N-OR7, > R4 et R5 représentent un atome d'hydrogène ou d'halogène, ou un groupement alkyle, alkoxy, alkylamino, ou dialkylamino, > A est tel que défini dans la description, > B représente un groupement alkyle ou alkényle substitués par un groupement -CHR8R9
PCT/FR2007/001174 2006-07-10 2007-07-09 Nouveaux derives tetracycuques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent WO2008006969A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0606247A FR2903404B1 (fr) 2006-07-10 2006-07-10 Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR06.06247 2006-07-10

Publications (2)

Publication Number Publication Date
WO2008006969A2 WO2008006969A2 (fr) 2008-01-17
WO2008006969A3 true WO2008006969A3 (fr) 2008-05-15

Family

ID=37722239

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/001174 WO2008006969A2 (fr) 2006-07-10 2007-07-09 Nouveaux derives tetracycuques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (3)

Country Link
AR (1) AR061835A1 (fr)
FR (1) FR2903404B1 (fr)
WO (1) WO2008006969A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
WO2011107494A1 (fr) 2010-03-03 2011-09-09 Sanofi Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
DE102010015123A1 (de) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
WO2011157827A1 (fr) 2010-06-18 2011-12-22 Sanofi Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (fr) 2011-09-12 2013-03-21 Sanofi Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
EP2760862B1 (fr) 2011-09-27 2015-10-21 Sanofi Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
WO2013068486A1 (fr) 2011-11-08 2013-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes pour le diagnostic et le traitement de l'infertilité masculine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057002A1 (fr) * 2000-02-02 2001-08-09 Les Laboratoires Servier Derives d'azoles condenses et leur utilisation comme agents hypoglycemiants
US7071221B2 (en) * 2003-07-28 2006-07-04 Les Laboratoires Servier Heterocyclic oxime compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057002A1 (fr) * 2000-02-02 2001-08-09 Les Laboratoires Servier Derives d'azoles condenses et leur utilisation comme agents hypoglycemiants
US7071221B2 (en) * 2003-07-28 2006-07-04 Les Laboratoires Servier Heterocyclic oxime compounds

Also Published As

Publication number Publication date
WO2008006969A2 (fr) 2008-01-17
AR061835A1 (es) 2008-09-24
FR2903404B1 (fr) 2008-08-22
FR2903404A1 (fr) 2008-01-11

Similar Documents

Publication Publication Date Title
WO2008006969A3 (fr) Nouveaux derives tetracycuques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW200732306A (en) Pyrimidine derivatives
WO2007061360A3 (fr) Nouveau composes
TW200637869A (en) The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
WO2008114817A1 (fr) Nouveau composé d'adénine
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
WO2007060257A3 (fr) Dicetopyrrolo-pyrroles
WO2008081096A3 (fr) Derives quinolinyliques, leur procede de preparation. les compositions pharmaceutiques qui les contiennent et leur utilisation comme agents hypoglycemiants et hypoli pemiants
WO2007147771A3 (fr) Dérivés tétraline et indane et leurs utilisations
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
WO2008136444A1 (fr) Dérivé hétérocyclique fusionné
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
MY183326A (en) New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
JO2616B1 (ar) مركبات ثلاثية الحلقات جديدة، طريقة من أجل تحضيرها ومركباتها الصيدلانية
WO2008003854A3 (fr) Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
WO2007134149A3 (fr) Dérivés de 3,4-dihydro-2h-benzo[1,4]oxazine et thiazine en tant qu'inhibiteurs de cetp
PT1753712E (pt) Derivados de amino-propanol
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
TW200722418A (en) Novel compounds
IL173895A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
MX2009004006A (es) Derivados de indol novedosos, proceso para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
TW200609223A (en) Process for the preparation of n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
TW200626600A (en) Octahydropyrrolo[3, 4-c]pyrrole derivatives

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07823267

Country of ref document: EP

Kind code of ref document: A2